Gestational diabetes, inflammation, and late vascular disease (Q37030452)

17 August 2017

1 reference

title

Gestational diabetes, inflammation, and late vascular disease (English)

1 reference

17 August 2017

0 references

0 references

Volpe L

1

1 reference

17 August 2017

Di Cianni G

2

1 reference

17 August 2017

Lencioni C

3

1 reference

17 August 2017

Cuccuru I

4

1 reference

17 August 2017

Benzi L

5

1 reference

17 August 2017

Del Prato S

6

1 reference

17 August 2017

1 November 2007

1 reference

Journal of Endocrinological Investigation

17 August 2017

1 reference

17 August 2017

30

1 reference

17 August 2017

10

1 reference

17 August 2017

873-879

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03349231

17 August 2017

0 references

cites work

Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Inflammation and the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Intermediate metabolism in normal pregnancy and in gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Maternal C-reactive protein levels are raised at 4 weeks gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

First-trimester C-reactive protein and subsequent gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

C-reactive protein and gestational diabetes: the central role of maternal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

TNF-alpha is a predictor of insulin resistance in human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Adiponectin is associated with vascular function independent of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Altered placental oxidative stress status in gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Gestational diabetes induces placental genes for chronic stress and inflammatory pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Insulin resistance syndrome in women with prior history of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Inflammatory markers in women with a recent history of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Abnormal carbohydrate metabolism during pregnancy : association with endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Vascular function in women with previous gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Elevation of soluble E-selectin levels following gestational diabetes is restricted to women with persistent abnormalities of glucose regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Endothelium-derived nitric oxide metabolites and soluble intercellular adhesion molecule-1 in diabetic and normal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349231

Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, Switzerland

21 January 2018

1 reference

12 December 2020

Study on the association between gestational diabetes mellitus and tumor necrosis factor-alpha gene polymorphism

1 reference

12 December 2020

Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus

1 reference

12 December 2020

Should we consider gestational diabetes a vascular risk factor?

1 reference

12 December 2020

A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus

1 reference

12 December 2020

C-reactive protein and metabolic syndrome in women with previous gestational diabetes

1 reference

12 December 2020

Gestational diabetes mellitus

1 reference

12 December 2020

Adiponectin is reduced in gestational diabetes mellitus in normal weight women

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03349231

1 reference

17 August 2017

1 reference